Buckingham Cuts Hospira (HSP) to Neutral
Tweet Send to a FriendGet Alerts HSP Hot Sheet
Price: $36.59 --0%
Rating Summary:
4 Buy, 11 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 1
Rating Summary:
4 Buy, 11 Hold, 2 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 1
Trade HSP Now!
An analyst at Buckingham Research downgraded shares of Hospira (NYSE: HSP) from Buy to Neutral in an intraday research note.
The lowered investment rating follows a reduced outlook from Hospira this morning. The stock is down more than 20 percent Tuesday afternoon.
For more ratings news on Hospira click here and for the rating history of Hospira click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The lowered investment rating follows a reduced outlook from Hospira this morning. The stock is down more than 20 percent Tuesday afternoon.
For more ratings news on Hospira click here and for the rating history of Hospira click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
- Barclays Downgrades American Capital Agency (AGNC) to Equalweight
- BofA/Merrill Lynch Downgrades Genomic Health Inc. (GHDX) to Neutral
Create E-mail Alert Related Categories
DowngradesRelated Entities
Buckingham Research
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
